Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial


Creative Commons License

Barlesi F., Vansteenkiste J., Spigel D., Ishii H., Garassino M., De Marinis F., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.10, 2018 (SCI-Expanded, Scopus) identifier